SUNITINIB MSN sunitinib (as malate) 12.5 mg hard capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

sunitinib msn sunitinib (as malate) 12.5 mg hard capsule bottle

accelagen pty ltd - sunitinib malate, quantity: 16.706 mg (equivalent: sunitinib, qty 12.5 mg) - capsule, hard - excipient ingredients: magnesium stearate; mannitol; titanium dioxide; croscarmellose sodium; gelatin; pregelatinised maize starch; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - sunitinib msn is indicated for;,treatment of advanced renal cell carcinoma (rcc),treatment of gastrointestinal stromal tumour (gist) after failure of imatinib mesilate treatment due to resistance or intolerance,treatment of unresectable, well-differentiated pancreatic neuroendocrine tumours (pancreatic net)

SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sunitinib msn sunitinib (as malate) 25 mg hard capsule blister pack

accelagen pty ltd - sunitinib malate, quantity: 33.412 mg (equivalent: sunitinib, qty 25 mg) - capsule, hard - excipient ingredients: iron oxide yellow; mannitol; croscarmellose sodium; titanium dioxide; iron oxide red; gelatin; pregelatinised maize starch; magnesium stearate; iron oxide black; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - sunitinib msn is indicated for;,treatment of advanced renal cell carcinoma (rcc),treatment of gastrointestinal stromal tumour (gist) after failure of imatinib mesilate treatment due to resistance or intolerance,treatment of unresectable, well-differentiated pancreatic neuroendocrine tumours (pancreatic net)

Sunitinib Mylan 12.5mg hard capsules Malta - English - Medicines Authority

sunitinib mylan 12.5mg hard capsules

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Mylan 25mg hard capsules Malta - English - Medicines Authority

sunitinib mylan 25mg hard capsules

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib Mylan 37.5mg hard capsules Malta - English - Medicines Authority

sunitinib mylan 37.5mg hard capsules

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib Mylan 50mg hard capsules Malta - English - Medicines Authority

sunitinib mylan 50mg hard capsules

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Sunitinib Bluefish 12.5 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

sunitinib bluefish 12.5 mg hard capsules

bluefish pharmaceuticals ab - sunitinib - capsule, hard - sunitinib

Sunitinib Bluefish 25 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

sunitinib bluefish 25 mg hard capsules

bluefish pharmaceuticals ab - sunitinib - capsule, hard - sunitinib

Sunitinib Bluefish 50 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

sunitinib bluefish 50 mg hard capsules

bluefish pharmaceuticals ab - sunitinib - capsule, hard - sunitinib

Sunitinib Rowex 12.5 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

sunitinib rowex 12.5 mg hard capsules

rowex ltd - sunitinib - capsule, hard - 12.5 milligram(s) - protein kinase inhibitors; sunitinib